Global & US Botulism Illness Market Research Report - Forecast to 2030

Global & US Botulism Illness Market by Drug types (antibiotics, antitoxins, others (trivalent, heptavalent) and by Applications (hospitals, pharmacies, clinics, others) Forecast: 2022-2030

ID: MRFR/Pharma/0292-HCR | 205 Pages | Published By Kinjoll Dey on March 2023         

Botulism Illness Market: Introduction

The Global & US Botulism Illness Market is expected to reach USD 3356.8 Million by 2030 at 4.90% CAGR during the forecast period 2022-2030. Botulism is one of the very serious and rare potentially critical illnesses which are caused by the toxins produces by a bacteria Clostridium botulinum. This type of disease mostly happens due to trouble seeing, weakness, trouble speaking and feeling tired. The major symptoms which can be classified under botulism illness are wound botulism, food borne botulism, and infant botulism and by inhalations. These symptoms are not only caused by the bacteria or bacterium itself but can also by the toxins which are produced by the bacteria.  It can occur in the human body by eating contaminated food, weak immune system and improper food. These symptoms generally appear with in 1 to 2 days or maximum 8 to 10 days after exposure.

Global Botulism Illness Market: Overview Though botulism illness is a very severe disease but it can be treated with supportive care and antitoxins. Monitoring the respiratory function of an individual can be a supportive care for botulism illness. In the wound botulism and food borne case, the antitoxins are required for proper treatment. The wounds are mostly treated by surgical procedure by which the bacteria can be removed by giving proper antibiotics.  Whenever there is breathing problem, the mechanical ventilators are required and in case of swallowing or speaking problem the rehabilitation therapies are needed. The government has taken initiative proposed the healthcare associations that the contaminated and waste food to be removed from the retail store and available places. Children are more prone to this disease.

Global Botulism Illness: Market Growth Influencer The major driving factors considered for the global botulism illness market are the availability of proper treatment of botulism illness, huge spending on research and development activities, clean environment. In addition to this, the government is taking proper initiative and working on the hygiene factor in many countries. Rising awareness about the care and treatment are easily available in the North America and European region. Along with this, the different health associations of countries such as in the US, the Centers for Disease Control and Prevention, World Health Organization and others are putting positive efforts; however, the botulism illness is getting irradiated gradually.  On the other hand, lack of awareness in some undeveloped regions, intake on unhygienic food and high cost of research & development are hindering the overall global botulism illness market.

Global Botulism Illness: Market Segmentation The global botulism illness market is segmented into the drug types and applications. Considering the drug type, the global botulism illness market is segmented into antibiotics, antitoxins and others (heptavalent botulinum and trivalent) and by application, the global botulism illness market is segmented into hospitals, clinics, pharmacies and others.

Global Botulism Illness Market: Regional Analysis Geographically, the global botulism illness market is divided into North America, Latin America, Western Europe, Eastern Europe, Asia-Pacific and Middle East & Africa.

North America: In North America, the US is one of the major markets for the treatment of botulism illness. The Centers for Disease Control and Prevention in the US has been looking forward to the proper treatment and care. Rising awareness and proper diagnose has meet the expectation of the North America, particularly in the US region. According to CDC (The Centers for Disease Control and Prevention) on an average 140 to 150 botulism cases report where in about 60% are of infant botulism, 18% are of wound botulism and 15% are of food borne. 

Europe:Followed by North America, European medical and healthcare associations along with WHO has implemented the proper treatment for botulism illness. In the recent, United Kingdom has reported large number of food borne botulism cases and control measures included the pause of production of all yogurt.

Asia-Pacific:Australian & New Zealand are the key market for the treatment for botulism illness because of the free medical policies for infants. Even though, the government initiative and rising awareness are pushing the botulism illness market.

Middle East & Africa:In MEA, several countries are undeveloped where the government is lagging behind giving proper treatment for botulism illness. So, capturing botulism illness market can be good opportunity for the manufacturers and service providers.

Global Botulism Illness Market: Key Players The existing and prominent key players present in the Global Botulism Illness Market include


  • MarketMicrobiotix

  • XOMA Corporation

  • Molecular Targeting Technologies

  • AlphaVax

  • Morphotek


Market Research Future introduces about 2016 Global Botulism Illness Market during the forecast period 2016-2027 which mainly includes the growth drivers, trends and restraints and how the market will grow in the future across the globe. In this report, Market Research Future has focused on the current market scenario which includes market segmentation, market dynamics, and competitive landscape along with company profiles.

The botulism illness market reports also covers brief analysis of Geographical Region includes:


- North America (US, Canada)

- Latin America (Argentina, Brazil, Mexico, Rest of LATAM)


- Western Europe (Germany, France, Italy, Spain, U.K, Rest of Western Europe)

- Eastern Europe (Poland, Russia)

Asia ‚Äď Pacific

- Asia (China, India, Japan, South Korea, Rest of Asia)

- Pacific Countries (Australia, New Zealand)

Middle East & Africa

- Middle East (Saudi, Qatar, UAE)

- Rest of Middle East (Africa, South Africa, Rest of Africa)

Every report of Market Research Future comprises of extensive primary research along with the detailed analysis of qualitative as well as quantitative aspects by various industry experts, key opinion leaders to gain the deeper insight of the market and industry performance. The report gives the clear picture of current market scenario which includes historical and projected botulism illness market size in terms of value and volume, technological advancement, macro economical and governing factors in the botulism illness market. The report also gives a broad study of the different market segments and regions.

Report Scope:

Report Attribute/Metric Details
  Market Size   USD 3356.8 Million
  CAGR   4.90%
  Base Year   2021
  Forecast Period   2022-2030
  Historical Data   2020
  Forecast Units    Value (USD Million)
  Report Coverage   Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
  Segments Covered   By Drug types, By Applications
  Geographies Covered    North America, Europe, Asia-Pacific, and Rest of the World (RoW)
  Key Vendors   Microbiotix, Inc., XOMA Corporation, Molecular Targeting Technologies, Inc., AlphaVax, Inc., and Morphotek, Inc. and others
  Key Market Opportunities

  • The availability of proper treatment of botulism illness
  • Huge spending on research and development activities
  • Clean environment
  •   Key Market Drivers   Rising awareness about the care and treatment

    Speak to Analyst Ask for Customization